Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Campylobacter jejuni

International Journal of Cancer

Volumn 66, Issue 2, 1996, Pages 184-190

  Ritter, Gerd ^a   Fortunato, Sheila R ^a   Cohen, Leonard ^a   Noguchi, Yuji ^a   Bernard, Edward M ^a   Stockert, Elisabeth ^a   Old, Lloyd J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GANGLIOSIDE GM2; TUMOR VACCINE;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CAMPYLOBACTER JEJUNI; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNIZATION; IMMUNOGENICITY; MELANOMA; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CAMPYLOBACTER JEJUNI; CARBOHYDRATE SEQUENCE; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; G(M2) GANGLIOSIDE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDES; MICE; MOLECULAR SEQUENCE DATA; RABBITS; VACCINES;

EID: 0029990514     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960410)66:2<184::AID-IJC8>3.0.CO;2-Z     Document Type: Article

References (27)

1. ALVING, C.R., Lipopolysaccharides, lipid A and liposomes containing Iipid A as immunologic adjuvants. Immunobiology, 187, 430-446 (1993).
2. ASPINALL, G.O., FUJIMOTO, S., MCDONALD, A.G., PANG, H., KURJANCZYK, L.A. and PENNER, J.L., Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barre-syndrome patients mimic human gangliosides in structure. Infect. Immun., 62, 2122-2125 (1994).
3. ASPINALL, G.O., MCDONALD, A.G., RAJU, T.S., PANG, H., MORAN, P.A. and PENNER, J.L., Chemical structures of the core regions of Campylobacter jejunt serotypes O:1, O:4, O:23 and O:36 lipopolysaccharides. Europ. J. Biochem., 213, 1017-1027 (1993).
4. GOLDMAN, R.C. and LEIVE, L., Electrophoretic separation of lipopolysaccharide monomers differing in polysaccharide length. Methods Enzymol., 138, 267-275 (1987).
5. HAMILTON, W.B., HELLING, F., LLOYD, K.O. and LIVINGSTON, P.O., Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography. Int. J. Cancer., 53, 566-573 (1993).
6. KENSIL, C.R., PATEL, U., LENNICK, M. and MARCIANI, D., Separation and characterization of saponins with adjuvant activity from Qillaja saponaria molina cortex. J. Immunol., 146, 431-437 (1991).
7. KITAMURA, K., LIVINGSTON, P.O., FORTUNATO, S.R., STOCKERT, E., HELLING, F., RITTER, G., OETTGEN, H.F. and OLD, L.J., Serological response of melanoma patients to a GM2-ganglioside vaccine. Proc. nat. Acad. Sci. (Wash ), 92, 2805-2809 (1995).
8. y determinants. Proc. nat. Acad. Sci. (Wash.), 91, 12957-12961 (1994).
9. LIVINGSTON, P.O., ADLURI, S., HELLING, F., YAO, T.-J., KENSIL, C.R., NEWMAN, M.M. and MARCIANI, D., Phase-1 trial of immunological adjuvant QS-21 with a GM2-ganglioside-keyhole-limpet-haemocyaninconjugate vaccine in patients with malignant melanoma. Vaccine, 12, 1275-1280 (1994a).
10. LIVINGSTON, P.O., NATOLI, E.J., JONES CALVES, M., STOCKERT, E., OETTGEN, H.F. and OLD, L.J., Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients. Proc. nat. Acad. Sci. (Wash.), 84, 2911-2915 (1987).
11. LIVINGSTON, P.O., RITTER, G. and CALVES, M.J., Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse. Cancer Immunol. Immunother., 29, 179-184 (1989).
12. LIVINGSTON, P.O., WONG, G.Y.C., ADLURI, S., TAO, Y., PADAVAN, M., PARENTE, R., HANLON, C., CALVES, M., HELLING, F., RITTER, G., OETTGEN, H.F. and OLD, L.J., Improved survival in stage-III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. J Clin. Oncol., 12, 1036-1044 (1994b).
13. MOND, J.J., Vos, Q , LEES, A. and SNAPPER, C.M., T-cell-independent antigens. Curr. Opin. Immunol., 7, 349-354 (1995).
14. NATOLI, E.J., JR., LIVINGSTON, P.O., PUKEL, C.S., LLOYD, K.O., WIEGANDT, H., SZALAY, J., OETTOEN, H.F. and OLD, L.J., A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell-surface reactivity. Cancer Res., 46, 4116-4120 (1986).
15. OETTGEN, H.F. and OLD, L.J., The history of cancer immunotherapy. In: V. DeVita, S. Hellman and S.A. Rosenberg (eds.), Biologic therapy of cancer, J.B. Lippincott, Philadelphia (1991).
16. PFREUNDSCHUH, M , SHIKU, H., TAKAHASHI, T., UEDA, R., RANSOHOFF, J., OETTGEN, H.F. and OLD, L.J., Serological analysis of cell-surface antigens of malignant human brain tumors. Proc. nat. Acad. Sci. (Wash.), 75, 5122-5126 (1978).
17. RIETSCHEL, E.T., KIRIKAE, T., SCHADE, F.U., ULMER, A.J., HOLST, O., BRADE, H., SCHMIDT, G., MAMAT., U., GRIMMECKE, H.D., KUSUMOTO, S. and ZAEHRINGER, U., The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology, 187, 169-190 (1993).
18. RITTER, G., BOOSFELD, E., MARKSTEIN, E., YU, R.K., REN, S., OETTGEN, H.F., OLD, L.J. and LIVINGSTON, P.O., Biochemical and serological characteristics of natural 9-O-acetyl GD3 from human melanoma, bovine buttermilk and chemically O-acetylated GD3. Cancer Res., 50, 1403-1410 (1990).
19. RITTER, G. and LIVINGSTON, P.O., Ganglioside antigens expressed by human cancer cells. Semin. Cancer Biol., 2, 401-409 (1991).
20. SHIKU, H., TAKAHASHI, T., OETTGEN, H.F. and OLD, L.J., Cell-surface antigens of human malignant melanoma. J. exp. Med., 144, 873-881 (1976).
21. SVENNERHOLM, L., Chromatographic separation of human brain gangliosides. J. Neurochem., 10, 613-623 (1963).
22. TAI, T., CAHAN, L.D., TSUCHIDA, T., SAXTON, R.E., IRIE, R.F. and MORTON, D.L., Immunogenicity of melanoma-associated gangliosides in cancer patients. Int. J. Cancer, 35, 607-612 (1985).
23. WALSH, F.S., CRONIN, M., KOBLAR, S., DOHERTY, P., LEON, A. and HUGHES, R.A.C., Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barre syndrome. J Neuroimmunol., 34, 43-51 (1991).
24. WENG, N., RITTER, E., YUCEL, E., ZHANG, D., RITTER, G. and MARCUS, D.M., Specificity and structure of murine monoclonal antibodies against GM1 ganglioside. J. Neuroimmunol., 55, 61-68 (1994).
25. WESTPHAL, O., LUEDERITZ, O. and BISTER, F., Ueber die Extraktion von Bakterien mit Phenol/Wasser. Z. Naturforschg., 7b, 148-155 (1952).
26. YAMAGUCHI, H., FURUKAWA, K., FORTUNATO, S.R., LIVINGSTON, P.O., LLOYD, K.O., OETTGEN, H.F. and OLD, L.J., Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient. Proc. nat. Acad. Sci. (Wash.), 87, 3333-3337 (1990).
27. YUKI, N., TAKI, T., INAGAKI, F., KASAMA, T., TAKAHASHI, M., SAITO, K., HANDA, S. and MIATAKE, T., A bacterium lipopolysaccharide that elicits Guillam-Barre syndrome has a GM1-ganglioside-like structure. J. exp. Med., 178, 1771-1775 (1993).